Human Whole Exome Sequencing

Whole exome sequencing (WES) employs next-generation sequencing technology (NGS), which provides a cost-efficient alternative to whole genome sequencing (WGS). The human whole exome, composed by about 180,000 exons (protein-coding region of the genome) accounts for only 1-2% of the human genome, but up to 85% of the disease-related mutations associated with Mendelian disorders occur in these regions. By targeting these regions, human whole exome sequencing (hWES) provides an in-depth sequencing and analysis approach to indicate genome variants, germline mutations, somatic mutations, and pathogenic mechanisms. hWES service supports a broad range of studies for researchers, including genetic disease-related variants, complex diseases, cancer research, or human population genetics.

Category:

Novogene’s hWES service offers a convenient solution with plenty of profits, such as various panels to choose from, high-quality data, and publication-ready results that can help you achieve your research goals. Novogene also offers clinical-grade whole exome sequencing in clinical-grade sequencing laboratories validated and in compliance with CAP standards.

Applications

  • Human whole exome sequencing has been successfully helping researchers to obtain answers to many different and cutting-edge research and clinical questions:
  • Genome variant studies through exon detection
  • Pathogenic mechanism and molecular characterization of samples in research and clinical contexts
  • Cancer biopsy as a tool

Benefits

  • hWES focuses on the exome regions which can help achieve higher sequencing depth with significantly fewer data of good quality, compared with WGS.
  • hWES increases the sensitivity of the analysis which makes the detection of rare mutations easy.
  • Novogene’s extraordinary professional bioinformatics pipeline and internationally recognized software ensures that our customers always receive reliable and publication-ready data.

Specifications: DNA Sample Requirements

Platform Type Sample Type Amount (Qubit®) Purity
Illumina NovaSeq 6000 Genomic DNA ≥ 300 ng A260/280 = 1.8-2.0;
no degradation,no contamination
cfDNA/ctDNA ≥ 30 ng Fragments should be in multiples of 170 bp,
with no genomic
contamination
Genomic DNA from FFPE tissue ≥ 500 ng Fragments should be ≥ 1000 bp

Specifications: Sequencing and Analysis

Sequencing Platform Illumina NovaSeq 6000
Read Length Paired-end 150 bp
Sequencing Depth For Mendelian disorder/rare disease: effective sequencing depth above 50× (6G)
For tumor sample: effective sequencing depth above 100× (12G)
Data Analysis Data quality control

Alignment to a reference genome

SNP and InDel calling

Somatic SNP/InDel/CNV mutation detection (tumor-normal paired samples)

Project Workflow

From sample preparation, library preparation, DNA sequencing and data quality control, to bioinformatics analysis, Novogene provides high-quality products and professional services. Each step is performed in agreement with a high scientific standard and meticulous design to ensure high-quality research results.

Animal and Plant Whole Genome Sequencing

 

GeneSmart tự hào là đơn vị tiên phòng đầu tiên tại Việt Nam cung cấp giải pháp:

1. Giải trình tự tế bào đơn (SINGLE-CELL SEQUENCING);

2. Chuẩn bị mẫu tự động (AUTOMATED LIQUID HANDLING);

3. Xét nghiệm và chẩn đoán bệnh nhiễm (DIAGNOSIS OF INFECTIOUS DISEASE);

4. Sinh chiết lỏng (LIQUID BIOPSY)

5. Giải phẫu bệnh sinh học phân tử (MOLECULAR PATHOLOGY)

6. Nghiên cứu ung thư (CANCER RESEARCH)

7. Nghiên cứu miễn dịch (IMMUNOLOGY)

8. Khoa học hình sự (FORENSIC)

9. Trữ mẫu sinh học (Ngân hàng sinh học, BIOBANKING)

-----------------------

CÔNG TY TNHH KHOA HỌC CÔNG NGHỆ GENESMART (MST: 0315672982)

Địa chỉ: 65-67 Đường Số 5 - Cư xá Bình Thới, Phường 8, Quận 11, Thành phố Hồ Chí Minh.

Hotline: +84 947 528 778 | Website: https://genesmart.vn/

Email: [email protected] hoặc [email protected]

Download Flyer

Menu Ẩn